Regeneron Pharmaceuticals, Inc. (REGN) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Sanofi collaboration revenue | 1.62B | FY2025-Q3 |
| Non-GAAP net income per share - diluted | 11.83 USD_per_share | FY2025-Q3 |
| Bayer collaboration revenue | 345M | FY2025-Q3 |
| EYLEA United States Net Product Sales | 681M | FY2025-Q3 |
| EYLEA HD United States Net Product Sales | 431M | FY2025-Q3 |
| Total Net Product Sales | 1.59B | FY2025-Q3 |
| Other revenue | 198M | FY2025-Q3 |
Back to REGN overview · REGN earnings · REGN holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.